NCT00570622View on ClinicalTrials.gov

Effect of Pioglitazone on Portal and Systemic Hemodynamics in Patients With Advanced Cirrhosis

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
CirrhosisAscitesPortal Hypertension
Interventions
DRUG

Pioglitazone

Patients receive 60mg of pioglitazone once a day orally for 9 days

DRUG

Placebo

Patients receive placebo once a day orally for 9 days

Trial Locations (1)

1090

Internal Medicine III, Gastroenterology and Hepatology, Medical University of Vienna, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT00570622 - Effect of Pioglitazone on Portal and Systemic Hemodynamics in Patients With Advanced Cirrhosis | Biotech Hunter | Biotech Hunter